|
|
Article: Microchip Biotechnologies Raises $18.1M in Series B Financing.
- Article from:
- PR Newswire
- Article date:
- November 12, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PLEASANTON, Calif., Nov. 12 /PRNewswire/ -- Microchip Biotechnologies, Inc. (MBI), a provider of integrated life science systems for microsample preparation and analysis, today announced an $18.1M close of its Series B financing. The capital will fund the commercialization of the Apollo 100 System, a sample preparation system for Sanger DNA cycle sequencing, and the development of the Apollo platform for the rapidly growing Next-Generation Sequencing market and for emerging markets in DNA-based human identification and forensics.
The Series B financing was led by Domain Associates with Samsung Ventures, Western Technology Investment Inc. (WTI), and other ...